202 results on '"Taima, Kageaki"'
Search Results
2. Endocrine immune-related adverse event is a prognostic biomarker independent of lead-time bias
3. Role of G-protein-coupled estrogen receptor in the pathogenesis of chronic asthma
4. Rescue computed tomography-guided drainage of a giant mediastinal mature teratoma causing airway obstruction prior to surgical resection: a case report
5. Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia
6. The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer
7. A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non–small-cell Lung Cancer
8. [Retracted] Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study
9. Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung
10. Role of G-protein-coupled estrogen receptor in the pathogenesis of chronic asthma
11. Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study
12. Correlation of traction bronchiectasis with lung function decline in patients with interstitial lung diseases
13. Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer
14. Granulomatosis with Polyangiitis following COVID-19 in an Adolescent
15. Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702
16. Safety and feasibility of carboplatin and paclitaxel in combination with nintedanib for non-small cell lung cancer patients with idiopathic pulmonary fibrosis: a prospective pilot study
17. Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination
18. A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutations
19. Clinical application of immunocytochemical detection of ALK rearrangement on cytology slides for detection or screening of lung adenocarcinoma
20. Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia
21. Diabetic ketoacidosis shortly after COVID ‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD ‐1 and CTLA ‐4 inhibitors: A case report
22. Efficacy of pembrolizumab for patients with both high PD‐L1 expression and an MET exon 14 skipping mutation: A case report
23. A case of bullous pemphigoid with correlation to serum levels of anti‐BP180‐NC16a antibodies and thymus and activation‐regulated chemokine.
24. Immune‐mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non‐small cell lung cancer patient: A case report
25. The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non‐small cell lung cancer patients
26. Optimal next-generation sequencing (NGS) panel for estimating tumor mutation burden (TMB) and its clinical implication for non-small cell lung cancer (NSCLC).
27. Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
28. Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia
29. Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA
30. Polyinosinic-Polycytidylic Acid Induces the Expression of GRO-α in BEAS-2B Cells
31. Effect of Double-Stranded RNA on the Expression of Epithelial Neutrophil Activating Peptide-78/CXCL-5 in Human Endothelial Cells
32. Polyinosinic-polycytidylic acid the expression of GRO-[alpha] in BEAS-2B cells
33. Level of antibodies against mycobacterial glycolipid in the effusion for diagnosis of tuberculous pleural effusion
34. The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study
35. Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation
36. Procalcitonin Expression in Patients with Large Cell Neuroendocrine Carcinoma of the Lung
37. Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia
38. Phase II trial of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer.
39. Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab
40. A pilot study of adjuvant chemotherapy with carboplatin and oral S‐1 for patients with completely resected stage II to IIIA non‐small cell lung cancer
41. Effect of nintedanib on non‐small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review
42. Effect of peroxisome proliferator-activated receptor-γ ligands on the expression of retinoic acid-inducible gene-I in endothelial cells stimulated with lipopolysaccharide
43. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia
44. Expression of IP-10/CXCL10 Is Upregulated by Double-Stranded RNA in BEAS-2B Bronchial Epithelial Cells
45. Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with interferon-γ
46. A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
47. A Case of Large Cell Neuroendocrine Carcinoma Successfully Treated with Nivolumab
48. The efficacy of immune checkpoint inhibitors in advanced non‑small cell lung cancer harboring driver mutations
49. ショウニ ゼンソク ガ カンカイシタ ダイガクセイ ニオケル ハイ キノウ イジョウ
50. Real world study of afatinib in first-line or re-challenge setting for patients with EGFR mutant non-small cell lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.